PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,942 | +74.7% | 28,068 | +89.0% | 0.00% | – |
| Q2 2023 | $165,989 | 0.0% | 14,847 | 0.0% | 0.00% | – |
| Q1 2023 | $165,989 | -99.9% | 14,847 | +67.1% | 0.00% | – |
| Q1 2022 | $220,486,000 | -22.6% | 8,887 | 0.0% | 0.00% | – |
| Q4 2021 | $285,006,000 | +19.2% | 8,887 | +33.7% | 0.00% | – |
| Q3 2021 | $239,123,000 | -49.5% | 6,646 | -38.1% | 0.00% | – |
| Q2 2021 | $473,937,000 | – | 10,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |